down arrow

Sudarshan Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
29.53
-0.6 (-1.99%)
BSENSE

Apr 11, 12:37 PM

BSE+NSE Vol: 16000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
Operating Income
463.00
461.00
357.00
193.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
463.00
461.00
357.00
193.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-26.00
-22.00
-6.00
Raw Materials Consumed
430.00
457.00
358.00
184.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
Employee Cost
3.00
2.00
2.00
1.00
Operating Expenses
8.00
8.00
5.00
3.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1.00
1.00
1.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
440.00
446.00
346.00
186.00
Operating Profit (PBDIT) excl Other Income
22.00
14.00
10.00
7.00
Other Income
2.00
1.00
0.00
0.00
Operating Profit (PBDIT)
25.00
15.00
11.00
7.00
Interest
8.00
5.00
3.00
3.00
Profit before Depriciation and Tax
16.00
10.00
8.00
4.00
Depreciation
1.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
15.00
9.00
7.00
3.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
15.00
9.00
7.00
3.00
Provision for Tax
3.00
2.00
1.00
0.00
Profit After Tax
11.00
7.00
5.00
2.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
19.00
12.00
6.00
4.00
Profit Available for appropriations
30.00
19.00
12.00
6.00
Appropriations
30.00
19.00
12.00
6.00
Equity Dividend (%)
0.00%
3.00%
0.00%
0.00%
Earnings Per Share
4.76
5.48
5.46
2.74
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 0.48% vs 29.19% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 55.31% vs 34.56% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 65.57% vs 59.88% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 62.79% vs 34.07% in Mar 2023

Compare Profit and Loss Results of Sudarshan Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
463.00
10,334.00
-9,871.00
-95.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
463.00
10,334.00
-9,871.00
-95.52%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-94.00
87.00
92.55%
Raw Materials Consumed
430.00
3,263.00
-2,833.00
-86.82%
Power & Fuel Cost
0.00
129.00
-129.00
-100.00%
Employee Cost
3.00
2,274.00
-2,271.00
-99.87%
Operating Expenses
8.00
210.00
-202.00
-96.19%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
928.00
-927.00
-99.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
134.00
-134.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
440.00
7,798.00
-7,358.00
-94.36%
Operating Profit (PBDIT) excl Other Income
22.00
2,536.00
-2,514.00
-99.13%
Other Income
2.00
280.00
-278.00
-99.29%
Operating Profit (PBDIT)
25.00
2,817.00
-2,792.00
-99.11%
Interest
8.00
35.00
-27.00
-77.14%
Profit before Depriciation and Tax
16.00
2,782.00
-2,766.00
-99.42%
Depreciation
1.00
398.00
-397.00
-99.75%
Profit Before Taxation & Exceptional Items
15.00
2,384.00
-2,369.00
-99.37%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15.00
2,399.00
-2,384.00
-99.37%
Provision for Tax
3.00
457.00
-454.00
-99.34%
Profit After Tax
11.00
1,926.00
-1,915.00
-99.43%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
19.00
8,012.00
-7,993.00
-99.76%
Profit Available for appropriations
30.00
9,925.00
-9,895.00
-99.70%
Appropriations
30.00
9,925.00
-9,895.00
-99.70%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.76
47.75
-42.99
-90.03%
Profit And Loss - Net Sales
Net Sales 463.54 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 0.48% vs 29.19% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.81 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 55.31% vs 34.56% in Mar 2023

Profit And Loss - Interest
Interest 8.94 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 65.57% vs 59.88% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 11.46 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 62.79% vs 34.07% in Mar 2023